Breakthrough Therapy Status for LSD Formulation to Treat Generalized Anxiety Disorder

A clinical trial's positive results led to an LSD formulation receiving breakthrough therapy status from the FDA for treating generalized anxiety disorder. The drug by Mind Medicine Inc. showed promising efficacy and safety in phase 2b trials.